Abstract

<div class="authors authors-lg"><div class="author"><div class="author-img"><img src="https://bioinsightscdn.blob.core.windows.net/uploads/Jim lu 200x200.jpg" data-image="1"></div><div class="author-det"> <!--StartFragment--><b>Jim Lu </b>is the co-founder and CSO of TriArm Therapeutic Co., a company specializing in developing innovative cellular immunotherapies for unmet medical needs. Prior to joining TriArm Therapeutics, he worked at US FDA as a reviewer in the cell and gene therapy area. He was a recognized expert in this field and coauthored several FDA Guidance for Industries. Dr Lu was also the recipient of the CBER award for Excellence in Regulatory Science Research in 2015. Prior to joining the FDA, Dr Lu worked in the biotechnology industry as a senior scientist, manager and consultant in the development of viral vaccines and of viral vectors for cancer therapy.<!--EndFragment--> </div></div></div>

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.